Evidence map›Paper›PMID 36909629›Full record

ArticlebioRxiv : the preprint server for biology2023

Active maintenance of CD8

Brendan E Russ, Kirril Tsyganov, Sara Quon, Bingfei Yu, Jasmine Li, Jason K C Lee, Moshe Olshansky, Zhaohren He, Paul F Harrison, Adele Barugahare and 11 more

Open access · greenFull text readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 3 countries.

Brendan E RussDepartment of Microbiology, Immunity Theme, Biomedical Discovery Institute, Monash University.
Kirril TsyganovDepartment of Microbiology, Immunity Theme, Biomedical Discovery Institute, Monash University.
Sara QuonDepartment of Biological Sciences, University of California, San Diego, USA.
Bingfei YuDepartment of Biological Sciences, University of California, San Diego, USA.
Jasmine LiDepartment of Microbiology, Immunity Theme, Biomedical Discovery Institute, Monash University.
Jason K C LeeDepartment of Microbiology, Immunity Theme, Biomedical Discovery Institute, Monash University.
Moshe OlshanskyDepartment of Microbiology, Immunity Theme, Biomedical Discovery Institute, Monash University.
Zhaohren HeDepartment of Molecular Biology, University of California, San Diego, USA.
Paul F HarrisonBioinformatics platform, Biomedical Discovery Institute, Monash University, Australia.
Adele BarugahareDepartment of Microbiology, Immunity Theme, Biomedical Discovery Institute, Monash University.
Michael SeeBioinformatics platform, Biomedical Discovery Institute, Monash University, Australia.
Simone NussingPeter MacCallum Cancer Centre, Melbourne, Australia.
Alison E MoreyDepartment of Microbiology, Immunity Theme, Biomedical Discovery Institute, Monash University.
Vibha A UdupaDepartment of Microbiology, Immunity Theme, Biomedical Discovery Institute, Monash University.
Taylah J BennettDepartment of Microbiology, Immunity Theme, Biomedical Discovery Institute, Monash University.
Axel KalliesDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Australia.
Cornelis MurreDepartment of Molecular Biology, University of California, San Diego, USA.
Phillipe CollasDepartment of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
David PowellBioinformatics platform, Biomedical Discovery Institute, Monash University, Australia.
Ananda W GoldrathDepartment of Biological Sciences, University of California, San Diego, USA.
Stephen J TurnerDepartment of Microbiology, Immunity Theme, Biomedical Discovery Institute, Monash University.
Discovery Institute · USUniversity of California San Diego · USMonash University · AUOslo University Hospital · NOPeter MacCallum Cancer Centre · AUThe University of Melbourne · AU

Funding

The role of TCR, ligand, and signal strength in human γδ T cell developmentP01AI102853 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI Maria Ciofani · 2014 to 2026
$26.3M
NIAID NIH HHS P01 AI102853
6 · The paper itself

Abstract

The differentiation of naïve CD8

Identifiers

PMID36909629
PMCPMC10002700
OpenAlexW4322489599

What OpenQuestion holds

Textfull text, public
LicenceCC BY-ND
measurements read29
reference markers read4
identifiers read1
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.